基因芯片技术在检测肠道致病菌方面的应用

基因芯片技术具有高通量、自动化、快速检测等特点,因此被广泛地应用于各种研究领域,如细菌分子流行病学、细菌基因鉴定、致病分子机理、基因突变及多态性分析、表达谱分析、DNA测序和药物筛选等。现介绍基因芯片检测肠道致病菌方面的国外研究进展,基因芯片应用于检测肠道致病菌的3个方面:结合多重PCR对致病菌的毒力因子或者特异性基因进行鉴定;直接检测细菌的DNA或者RNA;以致病细菌核糖体RNA作为检测的靶基因同时检测多种肠道致病菌。由于其检测的高效率,该技术要优于其他分子生物学检测方法。基因芯片技术在肠道致病菌检测中有着巨大的应用价值,具有广阔的应用前景。     

Tn5转座突变技术在革兰氏阴性细菌分子遗传研究中的应用

随着广宿主载体系统的发展,Tn5及其衍生载体已经广泛应用于革兰氏阴性细菌的分子遗传学研究。主要综述了Tn5转座突变技术在生防细菌生防机理研究、细菌必需基因的鉴定、病原细菌毒力相关基因研究、代谢调控基因研究和菌株的遗传改良方面的应用研究进展。     

寡核苷酸芯片在微生物检测中的应用

近几年来发展起来的基因组研究技术———基因芯片技术为微生物检测提供了一种强有力的手段。目前国内外已广泛地开展了利用寡核苷酸芯片对多种微生物 (主要是病毒和细菌 ,少量有真菌 )进行相关检测的研究 ,并在对微生物病原体检测、种类鉴定、功能基因检测、基因分型、突变检测、基因组监测等方面获得了成功。由于寡核苷酸探针具有可根据研究需要任意设计、特异性高等特点 ,寡核苷酸芯片在微生物检测中有着巨大的应用价值 ,具有广阔的应用前景。     

高通量测序技术在细菌耐药中的应用

细菌耐药已成为威胁全球人类公共健康的重要因素之一,快速、准确明确细菌耐药的特性、机制及传播特征对疾病治疗及控制耐药菌的传播具有重要意义。高通量测序技术可以同时平行检测多个基因序列的状态,已广泛应用于细菌耐药检测。目前高通量测序技术在细菌耐药领域的应用主要有:全基因组测序技术、目标区域测序技术和宏基因组测序技术。所采用的测序平台主要为Illumina、Ion Torrent、BGI等二代测序和Pacific Biosciences、Oxford Nonopore 等三代测序平台。通过细菌耐药基因预测细菌耐药表型的准确性在很大程度上依赖于成熟的专业耐药基因数据库,各种通用型、特异型及隐马尔可夫模型耐药基因数据库的建立和完善,为高通量测序技术在细菌耐药领域的应用提供了坚实的基础。本文简要介绍了高通量测序技术、数据分析方法及相应测序平台在细菌耐药领域中的应用进展,并同时介绍了细菌耐药数据库的现状。     

双色荧光杂交芯片在检测 P 1A 1M P I 基C 因多态性中的应用

目的：应用一种新的高通量SNP检测方法-双色荧光杂交芯片技术检测CYPIA1 MspI基因多态性。方法：收集江苏汉族人群原发性肺癌患者75例和相应对照77例,应用双色荧光杂交芯片技术检测了152例样本的CYPIAI基因MspI基因多态性,并应用PCR-RFLP技术验证双色荧光杂交芯片的特异性。结果：152例样本的CYPIAI基因双色荧光杂交芯片技术分型结果与PCR-RFLP结果完全相符,两种方法的基因型分型结果具有很好的一致性。结论：双色荧光杂交芯片技术是一个高通量SNP检测的良好工具,特异性高,在大规模人群SNP筛检中具有良好的发展前案。     

冰核活性基因及其作报告基因的应用研究进展

国内外已经克隆了8个冰核活性基因,可用作报告基因,主要应用在植物－微生物互作研究、营养元素利用研究、病原微生物高敏检测和各种用途的细菌细胞表面展示等领域。     

分子生物学方法在食品微生物检测中的应用

近年来,食品安全受到广泛关注。及时、准确地检测出食品中的病原微生物是食品安全检测的重要内容,食品病原微生物的分子生物学检测技术因其特异性和灵敏性而备受瞩目。我们主要介绍了基因探针检测法、PCR检测法和基因芯片检测法的原理、开发及其在食品微生物检测中的应用。     

PCR技术检测食源性致病菌的研究进展

食源性致病菌的检测技术是食源性疾病预防与控制的关键环节。PCR是近年来广泛应用于食源性致病菌快速检测的方法之一。在食源性致病菌中,用于PCR检测的靶基因包括各种毒力基因、酶基因及特异性鉴别基因。这些靶基因的发现推动了食源性致病菌PCR快速检测的发展。     

植物病原细菌hrp基因研究进展

hrp基因决定植物病原细菌对寄主植物致病性和诱导非寄主及抗病寄主过敏性反应,hrp基因在植物和动物病原细菌中具有同源性,编码产物具有HR的激发子、调节和组成Ⅲ型泌出系统等功能,hrpM是P．sying合成β-(1,2)—葡聚糖必需的,除了Avr蛋白和harpins外致病性或毒性蛋白也可从Hrp系统泌出,表明hrp基因在病原细菌致病性和寄主范围等方面具有潜在作用。     

基于纳米金的显色基因芯片快速检测病原微生物

为构建一种新型的比色芯片,以实现对临床常见感染病原微生物的快速、准确地检测和鉴定.采用纳米金标记巯基修饰的各待检病原微生物的特异性基因片段,与相应的以各待检靶序列的特异性寡核苷酸探针构建成的基因芯片杂交,并通过结合银染反应将杂交信号被放大形成裸眼可见的显色信息来判读检测结果.该芯片技术检测时间短,最低检测值达 100fmol/L.操作方法简单,不需要特殊设备,能部分满足临床检测的通量要求,具有很好的临床应用前景.     

Therapeutic genes for cancer gene therapy

Cancer still represents a disease of high incidence and is therefore one major target for gene therapy approaches. Gene therapy for cancer implies that ideally selective tumor cell killing or inhibition of tumor cell growth can be achieved using nucleic acids (DNA and RNA) as the therapeutic agent. Therefore, the majority of cancer gene therapy strategies introduce foreign genes into tumor cells which aim at the immunological recognition and destruction, the direct killing of the target cells or the interference with tumor growth. To achieve this goal for gene therapy of cancer, a broad variety of therapeutic genes are currently under investigation in preclinical and in clinical studies. These genes are of very different origin and of different mechanisms of action, such as human cytokine genes, genes coding for immunstimulatory molecules/antigens, genes encoding bacterial or viral prodrug-activating enzymes (suicide genes), tumor suppressor genes, or multidrug resistance genes.     

The evolutionary history of quorum-sensing systems in bacteria

Communication among bacterial cells through quorum-sensing (QS) systems is used to regulate ecologically and medically important traits, including virulence to hosts. QS is widespread in bacteria; it has been demonstrated experimentally in diverse phylogenetic groups, and homologs to the implicated genes have been discovered in a large proportion of sequenced bacterial genomes. The widespread distribution of the underlying gene families (LuxI/R and LuxS) raises the questions of how often QS genes have been transferred among bacterial lineages and the extent to which genes in the same QS system exchange partners or coevolve. Phylogenetic analyses of the relevant gene families show that the genes annotated as LuxI/R inducer and receptor elements comprise two families with virtually no homology between them and with one family restricted to the gamma-Proteobacteria and the other more widely distributed. Within bacterial phyla, trees for the LuxS and the two LuxI/R families show broad agreement with the ribosomal RNA tree, suggesting that these systems have been continually present during the evolution of groups such as the Proteobacteria and the Firmicutes. However, lateral transfer can be inferred for some genes (e.g., from Firmicutes to some distantly related lineages for LuxS). In general, the inducer/receptor elements in the LuxI/R systems have evolved together with little exchange of partners, although loss or replacement of partners has occurred in several lineages of gamma-Proteobacteria, the group for which sampling is most intensive in current databases. For instance, in Pseudomonas aeruginosa, a transferred QS system has been incorporated into the pathway of a native one. Gene phylogenies for the main LuxI/R family in Pseudomonas species imply a complex history of lateral transfer, ancestral duplication, and gene loss within the genus.     

Tumor microenvironment as the “regulator” and “target” for gene therapy

In this review, we focus on strategies for designing functional nano gene carriers, as well as choosing therapeutic genes targeting the tumor microenvironment. Gene mutations have a great impact on the occurrence of cancer. Thus, gene therapy plays a major role in cancer therapy and has the potential to cure cancer. Well‐designed gene therapy largely relies on effective gene carriers, which can be divided into viral carriers and non‐viral carriers. A gene carrier delivers functional genes to their intracellular target and avoids nucleic acids being degraded by nucleases in the serum. Most conventional cancer gene therapies only target cancer cells and do not appear to be sufficintly efficient to pass clinical trials. Accumulating evidence has shown that extending the therapeutic strategies to the tumor microenvironment, rather than the tumor cell itself, can allow more options for achieving robust anti‐cancer efficiency. In addition, unusual features between tumor microenvironment and normal tissues, such as a lower pH, higher glutathione and reactive oxygen species concentrations, and overexpression of some enzymes, facilitate the design of smart stimuli‐responsive gene carriers regulated by the tumor microenvironment. These carriers interact with nucleic acids and then form stable nanoparticles under physiological conditions. By regulation of the tumor microenvironment, stimuli‐responsive gene carriers are able to change their properties and achieve high gene delivery efficiency. Considering the tumor microenvironment as the “regulator” and “target” when designing gene carriers and choosing therapeutic genes shows significant benefit with respect to improving the accuracy and efficiency of cancer gene therapy.     

水稻抗白叶枯病基因的鉴定、定位和克隆进展

由水稻黄单胞菌水稻变种Xoo引起的水稻白叶枯病是全球性的重要病害之一。已有31个水稻白叶枯抗性基因被鉴定并报道,其中18个被定位到染色体上,5个被克隆。简要综述了水稻白叶枯抗性基因的鉴定、定位和克隆的进展,并讨论了合理利用抗性基因防治白叶枯病的前景。     

人类与病原菌的军备竞赛:NDM-1耐药基因与超级细菌

在人类历史上,每一次诸如鼠疫和肺结核病等瘟疫的大流行,都曾给人类的生存带来巨大的威胁。抗生素的应用使人类掌握了抵抗细菌感染的锐利"武器",但同时病原菌也通过突变和水平基因转移等方式产生了诸多耐药基因,从而获得了应对抗生素杀伤的坚固"盾牌";于是人类又不断地开发新式抗生素"武器"来破解病原菌的耐药"盾牌"——一场"军备竞赛"愈演愈烈。近来研究发现,携带编码NDM-1基因的耐药质粒不仅可以在细菌间转移,而且能使所在宿主菌成为可以耐受几乎全部抗生素的超级细菌。但是,凭借着日益进步的科技和医学,以及科学的用药策略,我们一定可以再次战胜超级细菌。     

Horizontal gene transfer in eukaryotes: The weak‐link model

The significance of horizontal gene transfer (HGT) in eukaryotic evolution remains controversial. Although many eukaryotic genes are of bacterial origin, they are often interpreted as being derived from mitochondria or plastids. Because of their fixed gene pool and gene loss, however, mitochondria and plastids alone cannot adequately explain the presence of all, or even the majority, of bacterial genes in eukaryotes. Available data indicate that no insurmountable barrier to HGT exists, even in complex multicellular eukaryotes. In addition, the discovery of both recent and ancient HGT events in all major eukaryotic groups suggests that HGT has been a regular occurrence throughout the history of eukaryotic evolution. A model of HGT is proposed that suggests both unicellular and early developmental stages as likely entry points for foreign genes into multicellular eukaryotes.     

Frequent,independent transfers of a catabolic gene from bacteria to contrasted filamentous eukaryotes

Even genetically distant prokaryotes can exchange genes between them, and these horizontal gene transfer events play a central role in adaptation and evolution. While this was long thought to be restricted to prokaryotes, certain eukaryotes have acquired genes of bacterial origin. However, gene acquisitions in eukaryotes are thought to be much less important in magnitude than in prokaryotes. Here, we describe the complex evolutionary history of a bacterial catabolic gene that has been transferred repeatedly from different bacterial phyla to stramenopiles and fungi. Indeed, phylogenomic analysis pointed to multiple acquisitions of the gene in these filamentous eukaryotes—as many as 15 different events for 65 microeukaryotes. Furthermore, once transferred, this gene acquired introns and was found expressed in mRNA databases for most recipients. Our results show that effective inter-domain transfers and subsequent adaptation of a prokaryotic gene in eukaryotic cells can happen at an unprecedented magnitude.     

水稻抗白叶枯病基因及其应用研究进展

由黄单胞菌水稻变种Xanthomonas oryzae pv.Oryzae（Xoo）引起的白叶枯病是水稻重要病害之一。目前,已有37个水稻白叶枯抗性基因被鉴定并报道,其中28个被定位到染色体上,7个被克隆。本文简要综述了水稻白叶枯抗性基因的鉴定、定位和克隆的进展,并讨论了合理利用抗性基因防治白叶枯病的前景。     

Long-term expression of gene introduction into normal human T-lymphocytes by retroviral-mediated gene transfer

Human T-lymphocytes are long lived, easily accessible, mature, and capable of proliferation. They are theoretically a suitable target for retroviral mediated gene transfer. To test this hypothesis, normal human T-cells obtained from bone marrow and peripheral blood were stimulated with phytohemagglutinin (PHA) and infected 24 h later with the retroviral vector N2 which carries the bacterial neo gene. T-lymphocytes were propagated in culture for up to 14 weeks with interleukin-2 (IL-2). Analysis by whole cell RNA dot/blot using a single stranded RNA probe demonstrated persistent expression of the neo gene. Preliminary functional studies revealed that both helper and suppressor functions were preserved in the infected cells in culture. These results demonstrate that normal T-cells are capable of long-term expression of genes introduced by retroviral mediated gene transfer and are potential target cells for somatic gene therapy.